HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity

SG Deeks, AN Phillips - Bmj, 2009 - bmj.com
More than 25 antiretroviral drugs from six therapeutic classes are now available for the
management of HIV infection (box 1). Most patients who take medication achieve durable …

The role of HIV in serious diseases other than AIDS

AN Phillips, J Neaton, JD Lundgren - Aids, 2008 - journals.lww.com
Now that we are over 10 years into the HAART era in resource-rich countries the major
clinical impact of this therapy on reduced AIDS events and AIDS deaths has been well …

[HTML][HTML] Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label …

S McCormack, DT Dunn, M Desai, DI Dolling, M Gafos… - The Lancet, 2016 - thelancet.com
Background Randomised placebo-controlled trials have shown that daily oral pre-exposure
prophylaxis (PrEP) with tenofovir–emtricitabine reduces the risk of HIV infection. However …

Meta-analysis: Beyond the grand mean?

GD Smith, M Egger, AN Phillips - Bmj, 1997 - bmj.com
In the previous two articles 1 2 we outlined the potentials and principles of meta-analysis
and the practical steps in performing a meta-analysis. Now we will examine how to use meta …

Meta-analysis: principles and procedures

M Egger, GD Smith, AN Phillips - Bmj, 1997 - bmj.com
Meta-analysis is a statistical procedure that integrates the results of several independent
studies considered to be “combinable.” 1 Well conducted meta-analyses allow a more …

Initiation of antiretroviral therapy in early asymptomatic HIV infection.

JD Lundgren, AG Babiker, F Gordin… - The New England …, 2015 - europepmc.org
Background Data from randomized trials are lacking on the benefits and risks of initiating
antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) …

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

M Egger, M May, G Chêne, AN Phillips, B Ledergerber… - The Lancet, 2002 - thelancet.com
Background Insufficient data are available from single cohort studies to allow estimation of
the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral …

Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study

N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk… - Aids, 2003 - journals.lww.com
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD)
among HIV-infected persons, and to investigate any association between such risk factors …

Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy

AJ Rodger, V Cambiano, T Bruun, P Vernazza… - Jama, 2016 - jamanetwork.com
Importance A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral
therapy (ART) as a prevention strategy is the absolute risk of HIV transmission through …

[HTML][HTML] Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy …

AJ Rodger, V Cambiano, T Bruun, P Vernazza… - The Lancet, 2019 - thelancet.com
Background The level of evidence for HIV transmission risk through condomless sex in
serodifferent gay couples with the HIV-positive partner taking virally suppressive …